Related references
Note: Only part of the references are listed.Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma
Armando Tripodi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests
Emmanuel J. Favaloro
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
Patrick T. Ebbert et al.
HAEMOPHILIA (2020)
Clinical application of Web Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Patterns of blood sampling and patient characteristics among clinician users
Alanna McEneny-King et al.
HAEMOPHILIA (2020)
Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum
Juthakorn Poothong et al.
BLOOD (2020)
The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States
Lynn M. Malec et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
Peter Baker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
WFH Guidelines for the Management of Hemophilia, 3rd edition
Alok Srivastava et al.
HAEMOPHILIA (2020)
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A
Barbara A. Konkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The design of a Bayesian platform trial to prevent and eradicate inhibitors in patients with hemophilia
Marnie Bertolet et al.
BLOOD ADVANCES (2020)
Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A
Patrick T. Ebbert et al.
THROMBOSIS RESEARCH (2020)
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K. John Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice
Guy A. Young et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays
Joanne Adamkewicz et al.
THROMBOSIS AND HAEMOSTASIS (2019)
The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors
Margaret V. Ragni et al.
HAEMOPHILIA (2019)
Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia A
Jens Mueller et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
Amy D. Shapiro et al.
BLOOD (2019)
Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice Paper
Keith Gomez et al.
HAEMOPHILIA (2019)
Emicizumab use in major orthopedic surgery
Craig D. Seaman et al.
BLOOD ADVANCES (2019)
Shifting landscape of hemophilia therapy: Implications for current clinical laboratory coagulation assays
Hanny Al-Samkari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review
C. H. Miller
HAEMOPHILIA (2018)
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH
M. V. Ragni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Gene therapy in hemophilia A: a cost-effectiveness analysis
Nicoletta Machin et al.
BLOOD ADVANCES (2018)
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
K. J. Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative
Jill M. Johnsen et al.
BLOOD ADVANCES (2017)
Genetic diagnosis in hemophilia and von Willebrand disease
Laura L. Swystun et al.
BLOOD REVIEWS (2017)
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study
P. D. James et al.
HAEMOPHILIA (2016)
Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
Midori Shima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers
Debargh Dutta et al.
BLOOD ADVANCES (2016)
Preimplantation genetic diagnosis of hemophilia A
Ming Chen et al.
THROMBOSIS JOURNAL (2016)
Impact of inhibitors on hemophilia A mortality in the United States
Christopher E. Walsh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy
Lize F. D. van Vulpen et al.
BLOOD (2015)
One-stage vs. chromogenic assays in haemophilia A
Joachim J. Potgieter et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Current laboratory practices in the diagnosis and management of haemophilia: a global assessment
S. Kitchen et al.
HAEMOPHILIA (2015)
Individualizing prophylaxis in hemophilia: a review
Pia Petrini et al.
EXPERT REVIEW OF HEMATOLOGY (2015)
Definitions in hemophilia: communication from the SSC of the ISTH
V. S. Blanchette et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Samantha C. Gouw et al.
BLOOD (2013)
Prenatal diagnosis of haemophilia: our experience of 44 cases
Federica Zarrilli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study
C. H. Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia
N. Narkbunnam et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
The principal results of the International Immune Tolerance Study: a randomized dose comparison
Charles R. M. Hay et al.
BLOOD (2012)
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Samantha C. Gouw et al.
BLOOD (2012)
Diagnosis and treatment of intracranial hemorrhage in children with hemophilia
Kim Nagel et al.
BLOOD COAGULATION & FIBRINOLYSIS (2012)
Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance
C. H. Miller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage
M. E. R. van Meegeren et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Pharmaco-economic aspects of inhibitor treatment
Jenny Goudemand
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008)
C. Nakar et al.
HAEMOPHILIA (2010)
Risk factors for inhibitor formation in haemophilia: a prevalent case-control study
M. V. Ragni et al.
HAEMOPHILIA (2009)
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project
R. Kulkarni et al.
HAEMOPHILIA (2009)
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
A. Coppola et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Intracranial haemorrhage in haemophilia A and B
Rolf C. R. Ljung
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Marilyn J. Manco-Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hemophilia: A practical approach to genetic testing
RK Pruthi
MAYO CLINIC PROCEEDINGS (2005)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia
JM Soucie et al.
HAEMOPHILIA (2001)
Share Paper
